220 related articles for article (PubMed ID: 21543272)
1. Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry.
Teunissen SF; Jager NG; Rosing H; Schinkel AH; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1677-85. PubMed ID: 21543272
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry.
Teunissen SF; Rosing H; Koornstra RH; Linn SC; Schellens JH; Schinkel AH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2519-29. PubMed ID: 19589736
[TBL] [Abstract][Full Text] [Related]
3. An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients.
Dahmane E; Mercier T; Zanolari B; Cruchon S; Guignard N; Buclin T; Leyvraz S; Zaman K; Csajka C; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3402-14. PubMed ID: 21094101
[TBL] [Abstract][Full Text] [Related]
4. Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry.
Binkhorst L; Mathijssen RH; Ghobadi Moghaddam-Helmantel IM; de Bruijn P; van Gelder T; Wiemer EA; Loos WJ
J Pharm Biomed Anal; 2011 Dec; 56(5):1016-23. PubMed ID: 21872414
[TBL] [Abstract][Full Text] [Related]
5. Validation of a liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of Sotrastaurin and its metabolite N-desmethyl-sotrastaurin in human blood.
Jakab A; Winter S; Guy B; Raccuglia M; Picard F; Kovarik JM; Chudasama J; Guttikar S; Singhal P; Kretz O
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 897():10-6. PubMed ID: 22541169
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a liquid chromatography-tandem mass spectrometry assay for the analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and its metabolite 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) in plasma, urine, bile, intestinal contents, faeces and eight selected tissues from mice.
Teunissen SF; Vlaming ML; Rosing H; Schellens JH; Schinkel AH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(25):2353-62. PubMed ID: 20708442
[TBL] [Abstract][Full Text] [Related]
7. Liquid chromatography-mass spectrometry method for the quantification of tamoxifen and its metabolite 4-hydroxytamoxifen in rat plasma: application to interaction study with biochanin A (an isoflavone).
Singh SP; Wahajuddin ; Ali MM; Kohli K; Jain GK
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct; 879(27):2845-51. PubMed ID: 21890435
[TBL] [Abstract][Full Text] [Related]
8. Quantification of dimethyl-ifosfamide and its N-deschloropropylated metabolites in mouse plasma by liquid chromatography-tandem mass spectrometry.
Deroussent A; Rodriguez S; Martelli S; Seck A; Dubus-Daudigeos E; Desmaële D; Vassal G; Paci A
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(11-12):743-50. PubMed ID: 21377940
[TBL] [Abstract][Full Text] [Related]
9. Optimizing high-performance liquid chromatography method with fluorescence detection for quantification of tamoxifen and two metabolites in human plasma: application to a clinical study.
Zhu YB; Zhang Q; Zou JJ; Yu CX; Xiao DW
J Pharm Biomed Anal; 2008 Jan; 46(2):349-55. PubMed ID: 18037598
[TBL] [Abstract][Full Text] [Related]
10. Sensitive liquid chromatography/tandem mass spectrometry assay for absolute quantification of ITIH4-derived putative biomarker peptides in clinical serum samples.
van den Broek I; Sparidans RW; Schellens JH; Beijnen JH
Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1842-50. PubMed ID: 20533314
[TBL] [Abstract][Full Text] [Related]
11. In vitro cytochrome P450 activity: development and validation of a sensitive high performance liquid chromatography-tandem mass spectrometry method for the quantification of six probe metabolites after derivatization with pyridine-3-sulfonyl chloride in an aqueous environment.
De Bock L; Vande Casteele SR; Mulliez SM; Boussery K; Van Bocxlaer JF
J Chromatogr A; 2011 Feb; 1218(6):793-801. PubMed ID: 21194699
[TBL] [Abstract][Full Text] [Related]
12. Development of a high-performance liquid chromatography method with fluorescence detection for the routine quantification of tamoxifen, endoxifen and 4-hydroxytamoxifen in plasma from breast cancer patients.
Rangel-Méndez JA; Graniel-Sabido MJ; Sánchez-Cruz JF; Moo-Puc R
Biomed Chromatogr; 2019 Apr; 33(4):e4462. PubMed ID: 30536934
[TBL] [Abstract][Full Text] [Related]
13. Bioanalytical methods for determination of tamoxifen and its phase I metabolites: a review.
Teunissen SF; Rosing H; Schinkel AH; Schellens JH; Beijnen JH
Anal Chim Acta; 2010 Dec; 683(1):21-37. PubMed ID: 21094378
[TBL] [Abstract][Full Text] [Related]
14. Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
Poon GK; Chui YC; McCague R; Lłnning PE; Feng R; Rowlands MG; Jarman M
Drug Metab Dispos; 1993; 21(6):1119-24. PubMed ID: 7905393
[TBL] [Abstract][Full Text] [Related]
15. Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry.
Ter Heine R; Hillebrand MJ; Rosing H; van Gorp EC; Mulder JW; Beijnen JH; Huitema AD
J Pharm Biomed Anal; 2009 Feb; 49(2):451-8. PubMed ID: 19128911
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous quantification of rosiglitazone and its two major metabolites, N-desmethyl and p-hydroxy rosiglitazone in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study.
Kim KB; Lee DJ; Yeo CW; Shin JG; Bae SK
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(20-21):1951-6. PubMed ID: 19477697
[TBL] [Abstract][Full Text] [Related]
17. Determination of ticagrelor and two metabolites in plasma samples by liquid chromatography and mass spectrometry.
Sillén H; Cook M; Davis P
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(25):2299-306. PubMed ID: 20688583
[TBL] [Abstract][Full Text] [Related]
18. Selective and sensitive method for the determination of metoprolol in human plasma using liquid chromatography coupled with tandem mass spectrometry.
Venkateswarlu P; Kumar BN; Seshaiah K; Prasad VV
Acta Pharm; 2010 Jun; 60(2):177-84. PubMed ID: 21134854
[TBL] [Abstract][Full Text] [Related]
19. Assays for the quantification of melphalan and its hydrolysis products in human plasma by liquid chromatography-tandem mass spectrometry.
Mirkou A; Vignal B; Cohen S; Guillaumont M; Glehen O; Guitton J
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3089-96. PubMed ID: 19674945
[TBL] [Abstract][Full Text] [Related]
20. Validation of a quantitative assay for human neutrophil peptide-1, -2, and -3 in human plasma and serum by liquid chromatography coupled to tandem mass spectrometry.
van den Broek I; Sparidans RW; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1085-92. PubMed ID: 20356805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
